CSL to manufacture and supply vaccine candidates

CSL Media Statement on COVID19 Vaccine Manufacture

Development of the University of Queensland’s vaccine candidate remains CSL’s priority.

At White House Roundtable, Paul Perreault Urges People to Donate Plasma in the Fight Against COVID-19

Inaccurate Report of COVID-19 Vaccine Agreement

The report made by the Courier Mail and other media agencies today that an agreement has been struck to specifically secure s…

Rare Diseases in Asia-Pacific

Economist Intelligence Unit (EIU) Report launched today reveals only one in three rare disease patients receives the best-ava…

CSL’s Global Role in Battling COVID-19

Here is how CSL is working around the world with academia, industry and governments to combat the novel coronavirus COVID-19 …

UQ COVID 19 Vaccine to Commence Human Trials

Today, the first human trials using the University of Queensland’s (UQ) COVID-19 vaccine have commenced in Australia

CSL Behring Begins Trial for Respiratory Distress

Phase II placebo-controlled study will assess the safety and efficacy of CSL312 for the treatment of patients with severe res…